BBOT
Price
$12.70
Change
-$0.78 (-5.79%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.02B
Intraday BUY SELL Signals
COCP
Price
$0.99
Change
-$0.03 (-2.94%)
Updated
Nov 19, 04:58 PM (EDT)
Capitalization
13.65M
Intraday BUY SELL Signals
Interact to see
Advertisement

BBOT vs COCP

Header iconBBOT vs COCP Comparison
Open Charts BBOT vs COCPBanner chart's image
BridgeBio Oncology Therapeutics
Price$12.70
Change-$0.78 (-5.79%)
Volume$3.74K
Capitalization1.02B
Cocrystal Pharma
Price$0.99
Change-$0.03 (-2.94%)
Volume$100
Capitalization13.65M
BBOT vs COCP Comparison Chart in %
BBOT
Daily Signal:
Gain/Loss:
COCP
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BBOT vs. COCP commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBOT is a Hold and COCP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (BBOT: $12.70 vs. COCP: $0.99)
Brand notoriety: BBOT and COCP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBOT: 51% vs. COCP: 16%
Market capitalization -- BBOT: $1.02B vs. COCP: $13.65M
BBOT [@Biotechnology] is valued at $1.02B. COCP’s [@Biotechnology] market capitalization is $13.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBOT’s FA Score shows that 1 FA rating(s) are green whileCOCP’s FA Score has 0 green FA rating(s).

  • BBOT’s FA Score: 1 green, 4 red.
  • COCP’s FA Score: 0 green, 5 red.
According to our system of comparison, BBOT is a better buy in the long-term than COCP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBOT’s TA Score shows that 5 TA indicator(s) are bullish while COCP’s TA Score has 4 bullish TA indicator(s).

  • BBOT’s TA Score: 5 bullish, 4 bearish.
  • COCP’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both BBOT and COCP are a good buy in the short-term.

Price Growth

BBOT (@Biotechnology) experienced а +0.55% price change this week, while COCP (@Biotechnology) price change was -9.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBOT($1.02B) has a higher market cap than COCP($13.6M). BBOT YTD gains are higher at: 20.952 vs. COCP (-50.985). COCP has higher annual earnings (EBITDA): -12.3M vs. BBOT (-94.43M). BBOT has more cash in the bank: 131M vs. COCP (4.77M). COCP has less debt than BBOT: COCP (1.66M) vs BBOT (2.83M). BBOT (0) and COCP (0) have equivalent revenues.
BBOTCOCPBBOT / COCP
Capitalization1.02B13.6M7,471%
EBITDA-94.43M-12.3M768%
Gain YTD20.952-50.985-41%
P/E RatioN/AN/A-
Revenue00-
Total Cash131M4.77M2,749%
Total Debt2.83M1.66M171%
FUNDAMENTALS RATINGS
COCP: Fundamental Ratings
COCP
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBOTCOCP
RSI
ODDS (%)
Bearish Trend 2 days ago
20%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
22%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
26%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
31%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
34%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
35%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
51%
Bullish Trend 24 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
39%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
33%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
33%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BBOT
Daily Signal:
Gain/Loss:
COCP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IBNYX25.650.05
+0.20%
Macquarie Balanced Fund Class Y
NPNCX51.23N/A
N/A
Neuberger Berman Large Cap Value C
APLIX13.09N/A
N/A
Cavanal Hill Hedged Equity Income Inv
DLHIX28.36-0.22
-0.77%
Macquarie Healthcare I
MIINX17.89-0.21
-1.16%
BNY Mellon International Inv

BBOT and

Correlation & Price change

A.I.dvisor tells us that BBOT and VKTX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBOT and VKTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
-5.79%
VKTX - BBOT
27%
Poorly correlated
-4.56%
COCP - BBOT
25%
Poorly correlated
-2.93%
QLGN - BBOT
24%
Poorly correlated
N/A
PRTC - BBOT
22%
Poorly correlated
+0.76%
RAPP - BBOT
22%
Poorly correlated
+6.16%
More

COCP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COCP has been loosely correlated with SGMO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if COCP jumps, then SGMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COCP
1D Price
Change %
COCP100%
-2.93%
SGMO - COCP
35%
Loosely correlated
-6.55%
FATE - COCP
34%
Loosely correlated
+2.94%
VKTX - COCP
31%
Poorly correlated
-4.56%
BYSI - COCP
28%
Poorly correlated
N/A
CYTK - COCP
27%
Poorly correlated
-2.12%
More